Lido Advisors
SLDB icon

Lido Advisors’s Solid Biosciences SLDB Stock Holding History

Lido Advisors’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$160K Sell
15,986
-14
-0.1% -$106 ﹤0.01% 1990
2026
Q1 		$115K Sell
16,000
-4,175
-21% -$26.8K ﹤0.01% 1844
2025
Q4 		$124K Hold
20,175
– – ﹤0.01% 1828
2025
Q3 		$124K Sell
20,175
-14
-0.1% -$82 ﹤0.01% 1739
2025
Q2 		$98.3K Hold
20,189
– – ﹤0.01% 1593
2025
Q1 		$74.7K Buy
+20,189
New +$86.4K ﹤0.01% 1461

Other funds holding SLDB

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Lido Advisors's SLDB Position: Q2 2026 in Review

Lido Advisors reduced its Solid Biosciences (SLDB) stake by 0.09% in Q2 2026, selling an estimated $106 and leaving 15,986 shares worth $160K. The position accounts for ﹤0.01% of the portfolio, ranked #1990.

Lido Advisors first reported a position in SLDB in Q1 2025 and has held it in 6 quarters since. 157 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

  • Lido Advisors held 15,986 shares of Solid Biosciences worth $160K as of Q2 2026.
  • Lido Advisors sold 14 Solid Biosciences shares in Q2 2026, an estimated $106.
  • Solid Biosciences made up ﹤0.01% of Lido Advisors's portfolio in Q2 2026, its #1990 holding.
  • Lido Advisors first reported a position in Solid Biosciences in Q1 2025 and has held it in 6 quarters since.
  • 157 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on Lido Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.